Progressive Tension Sutures in Gender Affirming Mastectomy

Sponsor
NYU Langone Health (Other)
Overall Status
Recruiting
CT.gov ID
NCT04818580
Collaborator
(none)
50
1
2
33.2
1.5

Study Details

Study Description

Brief Summary

50 patients seeking gender affirming mastectomy will be treated with different closure techniques in each side of their chest - one side will receive progressive tension sutures between pectoral fascia and the mastectomy flap, and the other side will not. Both sides will have drains in the mastectomy site. Rates of hematoma, seroma, and other complications will be compared between each chest side via standard statistical techniques for hypothesis testing.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Progressive Tension Sutures
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
A random number generator will be used. Subjects will be blinded as to which side of the chest has the sutures.
Primary Purpose:
Treatment
Official Title:
A Prospective Cohort Study Comparing the Effect of Progressive Tension Sutures and Drains to Drains Alone on Rates of Hematoma and Seroma in Gender Affirming Mastectomy for Transgender Men
Actual Study Start Date :
Mar 25, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Right-Sided Progressive Tension Sutures

Procedure: Progressive Tension Sutures
In each patient, one side of the chest will receive progressive tension sutures inside the mastectomy pocket, from pectoral fascia to underside of mastectomy flap. 2-0 Vicryl about 15-20 sutures per chest. Both sides will receive bilateral drains (standard of care)

Active Comparator: Left-Sided Progressive Tension Sutures

Procedure: Progressive Tension Sutures
In each patient, one side of the chest will receive progressive tension sutures inside the mastectomy pocket, from pectoral fascia to underside of mastectomy flap. 2-0 Vicryl about 15-20 sutures per chest. Both sides will receive bilateral drains (standard of care)

Outcome Measures

Primary Outcome Measures

  1. Total volume of Drain Fluid [Visit 2, Day 7]

    Participants will record drain outputs each time they empty drains in the Postoperative Drain Output Record (mL)

  2. Total volume of Drain Fluid [Visit 3, Day 14]

    Participants will record drain outputs each time they empty drains in the Postoperative Drain Output Record (mL)

  3. Total volume of Drain Fluid [Visit 4, Day 30]

    Participants will record drain outputs each time they empty drains in the Postoperative Drain Output Record (mL)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Being consulted for gender affirming mastectomy with the senior author (AH).

  2. 18 years of age at the time of enrollment.

  3. Transgender or gender nonbinary gender identity.

  4. All co-morbidities and all indications.

Exclusion Criteria:
  1. Age less than 18 years.

  2. BMI < 23.

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Alexes Hazen, MD FACS, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT04818580
Other Study ID Numbers:
  • 20-01803
First Posted:
Mar 26, 2021
Last Update Posted:
Mar 4, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by NYU Langone Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 4, 2022